221 related articles for article (PubMed ID: 11858797)
21. Pharmacological characterisation of native somatostatin receptors in AtT-20 mouse tumour corticotrophs.
Cervia D; Nunn C; Fehlmann D; Langenegger D; Schuepbach E; Hoyer D
Br J Pharmacol; 2003 May; 139(1):109-21. PubMed ID: 12746229
[TBL] [Abstract][Full Text] [Related]
22. Identification and pharmacological characterization of somatostatin receptors in rat lung.
Schloos J; Raulf F; Hoyer D; Bruns C
Br J Pharmacol; 1997 Jul; 121(5):963-71. PubMed ID: 9222554
[TBL] [Abstract][Full Text] [Related]
23. Characterization of cloned somatostatin receptors SSTR4 and SSTR5.
Raynor K; O'Carroll AM; Kong H; Yasuda K; Mahan LC; Bell GI; Reisine T
Mol Pharmacol; 1993 Aug; 44(2):385-92. PubMed ID: 8102785
[TBL] [Abstract][Full Text] [Related]
24. Rat somatostatin receptor type 1 couples to G proteins and inhibition of cyclic AMP accumulation.
Hadcock JR; Strnad J; Eppler CM
Mol Pharmacol; 1994 Mar; 45(3):410-6. PubMed ID: 8145728
[TBL] [Abstract][Full Text] [Related]
25. Binding and functional properties of the novel somatostatin analogue KE 108 at native mouse somatostatin receptors.
Cervia D; Langenegger D; Schuepbach E; Cammalleri M; Schoeffter P; Schmid HA; Bagnoli P; Hoyer D
Neuropharmacology; 2005 May; 48(6):881-93. PubMed ID: 15829258
[TBL] [Abstract][Full Text] [Related]
26. Somatostatin5 receptor-mediated [35S]guanosine-5'-O-(3-thio)triphosphate binding: agonist potencies and the influence of sodium chloride on intrinsic activity.
Williams AJ; Michel AD; Feniuk W; Humphrey PP
Mol Pharmacol; 1997 Jun; 51(6):1060-9. PubMed ID: 9187273
[TBL] [Abstract][Full Text] [Related]
27. Activation of adenylate cyclase by human recombinant sst5 receptors expressed in CHO-K1 cells and involvement of Galphas proteins.
Carruthers AM; Warner AJ; Michel AD; Feniuk W; Humphrey PP
Br J Pharmacol; 1999 Mar; 126(5):1221-9. PubMed ID: 10205012
[TBL] [Abstract][Full Text] [Related]
28. Identification and characterisation of heterogeneous somatostatin binding sites in rat distal colonic mucosa.
McKeen ES; Feniuk W; Michel AD; Kidd EJ; Humphrey PP
Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):543-9. PubMed ID: 8938650
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological profile of somatostatin and cortistatin receptors.
Siehler S; Nunn C; Hannon J; Feuerbach D; Hoyer D
Mol Cell Endocrinol; 2008 May; 286(1-2):26-34. PubMed ID: 18243519
[TBL] [Abstract][Full Text] [Related]
30. Autoradiographic analysis of somatostatin SRIF1 and SRIF2 receptors in the human brain and pituitary.
Thoss VS; Piwko C; Probst A; Hoyer D
Naunyn Schmiedebergs Arch Pharmacol; 1997 Feb; 355(2):168-76. PubMed ID: 9050008
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a biotinylated somatostatin analog as a receptor probe.
Schonbrunn A; Lee AB; Brown PJ
Endocrinology; 1993 Jan; 132(1):146-54. PubMed ID: 8093437
[TBL] [Abstract][Full Text] [Related]
32. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T
Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350
[TBL] [Abstract][Full Text] [Related]
33. Differences in the operational characteristics of the human recombinant somatostatin receptor types, sst1 and sst2, in mouse fibroblast (Ltk-) cells.
Castro SW; Buell G; Feniuk W; Humphrey PP
Br J Pharmacol; 1996 Feb; 117(4):639-46. PubMed ID: 8646408
[TBL] [Abstract][Full Text] [Related]
34. Selective somatostatin sst(2) receptor blockade with the novel cyclic octapeptide, CYN-154806.
Feniuk W; Jarvie E; Luo J; Humphrey PP
Neuropharmacology; 2000 Jun; 39(8):1443-50. PubMed ID: 10818260
[TBL] [Abstract][Full Text] [Related]
35. Pharmacological identity between somatostatin SS-2 binding sites and SSTR-1 receptors.
Hoyer D; Pérez J; Schoeffter P; Langenegger D; Schüpbach E; Kaupmann K; Lübbert H; Bruns C; Reubi JC
Eur J Pharmacol; 1995 Mar; 289(1):151-61. PubMed ID: 7781706
[TBL] [Abstract][Full Text] [Related]
36. Comparison of functional profiles at human recombinant somatostatin sst2 receptor: simultaneous determination of intracellular Ca2+ and luciferase expression in CHO-K1 cells.
Nunn C; Cervia D; Langenegger D; Tenaillon L; Bouhelal R; Hoyer D
Br J Pharmacol; 2004 May; 142(1):150-60. PubMed ID: 15037513
[TBL] [Abstract][Full Text] [Related]
37. Neuropeptide Y Y2 receptor and somatostatin sst2 receptor coupling to mobilization of intracellular calcium in SH-SY5Y human neuroblastoma cells.
Connor M; Yeo A; Henderson G
Br J Pharmacol; 1997 Feb; 120(3):455-63. PubMed ID: 9031749
[TBL] [Abstract][Full Text] [Related]
38. Porcine somatostatin receptor 2 displays typical pharmacological sst2 features but unique dynamics of homodimerization and internalization.
Durán-Prado M; Bucharles C; Gonzalez BJ; Vázquez-Martínez R; Martínez-Fuentes AJ; García-Navarro S; Rhodes SJ; Vaudry H; Malagón MM; Castaño JP
Endocrinology; 2007 Jan; 148(1):411-21. PubMed ID: 17053026
[TBL] [Abstract][Full Text] [Related]
39. [35S]Guanosine-5'-O-(3-thio)triphosphate binding as a measure of efficacy at human recombinant dopamine D4.4 receptors: actions of antiparkinsonian and antipsychotic agents.
Newman-Tancredi A; Audinot V; Chaput C; Verrièle L; Millan MJ
J Pharmacol Exp Ther; 1997 Jul; 282(1):181-91. PubMed ID: 9223553
[TBL] [Abstract][Full Text] [Related]
40. Pharmacological properties of two cloned somatostatin receptors.
Rens-Domiano S; Law SF; Yamada Y; Seino S; Bell GI; Reisine T
Mol Pharmacol; 1992 Jul; 42(1):28-34. PubMed ID: 1353250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
